PT518 – The EMBARK Model of Psychedelic Therapy, with Alex Belser, Ph.D. & Bill Brennan, Ph.D.
Psychedelics Today4 Kesä 2024

PT518 – The EMBARK Model of Psychedelic Therapy, with Alex Belser, Ph.D. & Bill Brennan, Ph.D.

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy.

When Belser and Brennan worked together at Cybin, they canvassed the field of psychedelic research and saw very little reporting (if any) of the manuals researchers were using, so they created the EMBARK model as a "big tent" framework – a way to understand what patients were going through from the perspective of six different clinical domains, where the clinician can go deeper into whichever domain is needed based on their specific skill sets. The EMBARK model has been used in two randomized controlled trials to date, and its corresponding book, EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person (co-authored by Belser and Brennan), was released in April.

They discuss:

  • The six domains and four ethical care cornerstones that make up EMBARK, as well as the many proposed change mechanisms that come into play
  • Concerns over facilitators stepping aside and letting the medicine do the work: How much of a factor is someone's presence in the room?
  • How much smaller, "little t" traumas can affect people – trauma doesn't always come from a single hallmark event
  • The need for facilitators to be trained well (and trauma-informed), as it's nearly impossible to tell when an adverse outcome is coming

and more!

For links, head to the show notes page.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(774)

PT568 – The 3-Axis Framework: A New Model for Psychedelic Work, with Pierre Bouchard, LPC, LM

PT568 – The 3-Axis Framework: A New Model for Psychedelic Work, with Pierre Bouchard, LPC, LM

In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry. Bouchard introduces h...

26 Marras 20241h 9min

PT567 – Sex and Psychedelics: Healing Through Altered States, with Bria Tavakoli, LPCC, MA, MS

PT567 – Sex and Psychedelics: Healing Through Altered States, with Bria Tavakoli, LPCC, MA, MS

In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her p...

22 Marras 20241h 13min

PT566 – Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry, with Juan Pablo Cappello

PT566 – Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry, with Juan Pablo Cappello

In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges ...

19 Marras 20241h 33min

PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.

PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.

In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketami...

15 Marras 20241h 8min

PT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel

PT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found t...

11 Marras 20241h 8min

PT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk

PT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, tri...

8 Marras 20241h 29min

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assist...

5 Marras 202445min

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

In this episode, Joe and Kyle finally meet up again for the first episode of Psychedelics Lately: the updated version of the much-missed Psychedelics Weekly, where they'll meet each month to talk abou...

1 Marras 202455min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
utelias-mieli
docemilia
rss-duodecim-lehti
rss-tiedetta-vai-tarinaa
rss-totuuden-liepeilla
university-of-eastern-finland
filocast-filosofian-perusteet
rss-bios-podcast
rss-duokkari-ekstra
rss-laakaripodi
rss-astetta-parempi-elama-podcast
rss-ylistys-elaimille